INTRODUCTION: The metabolic syndrome (MS) consists of the conjoint presence of risk factors for coronary. Several study groups have developed diagnostic criteria for MS, standing out those from the "Adult Treatment Panel III" (ATPIII), due to their wide utilization. Recently, the International Diabetes Federation (IDF) developed new diagnostic criteria for MS. OBJECTIVES: To evaluate the prevalence of MS in a group of women with severe obesity. To evaluate the prevalence of each one of the diagnostic criteria for MS. To compare the results obtained with the utilization of the ATPIII and the IDF criteria. To relate the results with the patients' age and Body Mass Index (BMI). SAMPLE AND METHODS: We evaluated 128 women (mean age = 38 years, sd = 11) with BMI equal to or higher than 35.0 kg/m2 (mean BMI = 46.5 kg/m2, sd = 6.5) on anthropometric measures (weight, height and waist circumference), analytically (fasting serum levels of triglycerides, HDL cholesterol and glucose), being also registered the values of systolic and diastolic blood pressure and age. RESULTS: The prevalence of MS in our sample following the ATPIII and the IDF criteria was, respectively, of 66.4% e 70.3%. The most frequently filled in criteria are those referring to waist circumference (ATPIII: 99.2%; IDF: 100%), blood pressure (77.3%) and HDL cholesterol (69.5%). Older patients and those with higher BMI fill in more criteria, being the diagnostic of MS associated to higher mean age and BMI. CONCLUSION: The prevalence of MS in women with severe obesity is high, being similar when the ATPIII or the IDF diagnostic criteria are used.
INTRODUCTION: The metabolic syndrome (MS) consists of the conjoint presence of risk factors for coronary. Several study groups have developed diagnostic criteria for MS, standing out those from the "Adult Treatment Panel III" (ATPIII), due to their wide utilization. Recently, the International Diabetes Federation (IDF) developed new diagnostic criteria for MS. OBJECTIVES: To evaluate the prevalence of MS in a group of women with severe obesity. To evaluate the prevalence of each one of the diagnostic criteria for MS. To compare the results obtained with the utilization of the ATPIII and the IDF criteria. To relate the results with the patients' age and Body Mass Index (BMI). SAMPLE AND METHODS: We evaluated 128 women (mean age = 38 years, sd = 11) with BMI equal to or higher than 35.0 kg/m2 (mean BMI = 46.5 kg/m2, sd = 6.5) on anthropometric measures (weight, height and waist circumference), analytically (fasting serum levels of triglycerides, HDL cholesterol and glucose), being also registered the values of systolic and diastolic blood pressure and age. RESULTS: The prevalence of MS in our sample following the ATPIII and the IDF criteria was, respectively, of 66.4% e 70.3%. The most frequently filled in criteria are those referring to waist circumference (ATPIII: 99.2%; IDF: 100%), blood pressure (77.3%) and HDL cholesterol (69.5%). Older patients and those with higher BMI fill in more criteria, being the diagnostic of MS associated to higher mean age and BMI. CONCLUSION: The prevalence of MS in women with severe obesity is high, being similar when the ATPIII or the IDF diagnostic criteria are used.
Authors: Raquel Munhoz da Silveira Campos; Ana Raimunda Dâmaso; Deborah Cristina Landi Masquio; Antonio Eduardo Aquino; Marcela Sene-Fiorese; Fernanda Oliveira Duarte; Lian Tock; Nivaldo Antonio Parizotto; Vanderlei Salvador Bagnato Journal: Lasers Med Sci Date: 2015-05-10 Impact factor: 3.161
Authors: Ana Raimunda Dâmaso; Aline de Piano; Raquel Munhoz da Silveira Campos; Flávia Campos Corgosinho; Wolfgang Siegfried; Danielle Arisa Caranti; Deborah Cristina Landi Masquio; June Carnier; Priscila de Lima Sanches; Patrícia Leão da Silva; Cláudia Maria Oller Nascimento; Lila Missae Oyama; Alexandre Dâmaso Aguilera Dantas; Marco Túlio de Mello; Sergio Tufik; Lian Tock Journal: Int J Endocrinol Date: 2013-10-27 Impact factor: 3.257
Authors: Shaoyong Xu; Bin Gao; Ying Xing; Jie Ming; Junxiang Bao; Qiang Zhang; Yi Wan; Qiuhe Ji Journal: PLoS One Date: 2013-10-23 Impact factor: 3.240